The cluster is dominated by a single large sale from the EVP of North America that is mechanically linked to option exercises, a classic cashless exercise pattern that does not convey negative information. The total dollar value is trivial relative to the $8.0B market cap (0.12%). Per academic literature, cluster sales are not predictive of negative returns, and the strong Q2 beat and raised pipeline outlook provide a positive fundamental backdrop. No bearish read-through is warranted.
Drug in focus
RYTM drug pipeline →IMCIVREE
▲ Bullish Named in this insider cluster- Impact
- Not rated
- Phase
- Not stated
- Time to market
- Not stated
- Next catalyst
- None dated
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 18 $115.25entry
- T+1 · 3mo ago +0.42%α +0.21% · $115.73
- T+5 · 3mo ago −1.65%α −1.45% · $113.35
- T+20 · 2mo ago −13.93%α −12.94% · $99.20
- T+60 · 6d ago −1.13%α +0.91% · $113.95
Price Chart
How similar events traded
Executive Summary
Three Rhythm Pharmaceuticals executives sold a total of $9.77M in open-market stock within a week of the company's strong Q2 2026 earnings beat. The sales are concentrated in the EVP of North America (Jennifer Kayden Lee, $8.9M) and follow a period of significant stock appreciation, suggesting profit-taking and option exercise monetization rather than a bearish signal on fundamentals.
Key Financial Metrics
Key Facts
- Three insiders sold a total of $9.77M in open-market stock from Aug 12-13, 2026.
- EVP Jennifer Kayden Lee accounted for $8.9M of the total, selling 75,834 shares at ~$117.38.
- All sales occurred 8-9 days after the company reported a Q2 2026 revenue beat ($71.3M vs $67.7M consensus) and a 12% EPS beat.
- The $9.77M in sales represents approximately 0.12% of RYTM's $8.0B market cap.
- Lee's sales were accompanied by the exercise of 56,601 stock options at $0-$24.29 strike prices, indicating a cashless exercise-and-sell pattern.
- CTO Joseph Shulman and CSO Alastair Garfield also sold shares totaling $608K and $913K respectively.
Financial Impact
$9.77M in insider sales, or 0.12% of market cap
Risk Factors
- Insider selling could accelerate if the stock continues to appreciate, creating overhead supply.
- The concentration of sales in the North America commercial head may signal a personal liquidity event rather than a company-specific concern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RYTM-1787004110005 |
Track record
26 reports on RYTM
9 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +32.06% at T+60 after the May 1, 2026 report. 11 of 14 went positive at some point.
Filters
- Nov 16, 2026today Press Release Bullish 5/10 Entry $107.48 Now $115.02 +7.02% settles Nov 24
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $110.68 to $112.16 Now $115.02 +3.92% ▲ +1.34% +2.25% vs SPY
- Nov 4, 202612d ago Press Release Bullish 5/10 Entry $110.68 to $112.16 Now $115.02 +3.92% ▲ +1.34% +2.25% vs SPY
- Nov 3, 202613d ago 8-K Bullish 6/10 No price data
- Nov 3, 202613d ago Press Release Bullish 6/10 Entry $86.44 to $113.95 Now $115.02 +33.06% ▲ +31.83% +32.41% vs SPY
- Nov 2, 202613d ago Press Release Neutral 5/10 Entry $86.44 to $113.95 Now $115.02 +33.06% ▲ +31.83% +32.41% vs SPY
- Oct 13, 20264w ago Press Release Bullish 6/10 Entry $86.71 to $88.62 Now $115.02 +32.65% ▲ +2.20% +1.75% vs SPY
- Oct 13, 20264w ago SC 13G Neutral 3/10 Entry $86.61 to $90.20 Now $115.02 +32.80% ▲ +4.14% +5.30% vs SPY
- Sep 14, 20269w ago 144 Bearish 5/10 Entry $96.77 to $99.27 Now $115.02 −18.86% ▼ −2.58% −0.47% vs SPY
- Aug 17, 202613w ago Insider Cluster Bearish 6/10 Entry $115.25 to $113.35 Now $115.02 +0.20% ▲ +1.65% +1.45% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers